LURASIDONE
Clinical Indication
Schizophrenia in adults aged 18 years and over.
Comments
Date of classification
November 2017
Review date
November 2017
Amber FULL SCA
Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.